This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
TGNA vs. GAIA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TGNA vs. GAIA: Which Stock Is the Better Value Option?
Why Gaia (GAIA) Could Be Positioned for a Surge
by Zacks Equity Research
Gaia (GAIA) is seeing positive earnings estimate revisions, suggesting that it could be a solid choice for investors.
Zacks.com featured highlights include: UFP Industries, Interactive Brokers Group, Avid Bioservices, Amtech Systems and Gaia
by Zacks Equity Research
Zacks.com featured highlights include: UFP Industries, Interactive Brokers Group, Avid Bioservices, Amtech Systems and Gaia
These 5 Stocks Are Safe Bets Courtesy of New Analyst Coverage
by Shrabana Mukherjee
Increased analyst coverage over the last few weeks might lead to solid price appreciation for stocks like UFP Industries (UFPI), Interactive Brokers (IBKR), Avid (CDMO), Amtech (ASYS) and GAIA
TGNA or GAIA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TGNA vs. GAIA: Which Stock Is the Better Value Option?
TGNA vs. GAIA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TGNA vs. GAIA: Which Stock Is the Better Value Option?
Gaiam (GAIA) Reports Next Week: What Awaits?
by Zacks Equity Research
Gaiam (GAIA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
TGNA vs. GAIA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
TGNA vs. GAIA: Which Stock Is the Better Value Option?
TGNA or GAIA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
TGNA vs. GAIA: Which Stock Is the Better Value Option?
FOXA vs. GAIA: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
FOXA vs. GAIA: Which Stock Is the Better Value Option?
Gaiam (GAIA) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Gaiam (GAIA) delivered earnings and revenue surprises of 633.33% and 3.65%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Gaiam (GAIA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Gaiam (GAIA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gaiam (GAIA) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
by Zacks Equity Research
Gaiam (GAIA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Are You Looking for a Top Momentum Pick? Why Gaiam (GAIA) is a Great Choice
by Zacks Equity Research
Does Gaiam (GAIA) have what it takes to be a top stock pick for momentum investors? Let's find out.
Is Gaia (GAIA) a Great Growth Stock?
by Zacks Equity Research
If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider Gaia (GAIA).
Buy These 5 Low Leverage Stocks to Weather Coronavirus Impact
by Aparajita Dutta
With the Q2 reporting cycle drawing to a close, investors must be eyeing stocks that exhibited solid earnings growth in the prior quarters. But choosing stocks with high debt level might be risky.
Gaiam (GAIA) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Gaiam (GAIA) delivered earnings and revenue surprises of 13.33% and 0.77%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Gaiam (GAIA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Gaiam (GAIA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Gaiam (GAIA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Gaiam (GAIA) delivered earnings and revenue surprises of -18.75% and -3.65%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Cue Biopharma, PJT Partners, Avenue Therapeutics, SpartanNash and Gaia
Pool Corp (POOL) Stock Up on Q1 Earnings and Revenue Beat
by Zacks Equity Research
Pool Corp's (POOL) first-quarter 2020 revenues reflect strong demand for discretionary products and higher sales growth of construction materials and products.
Rogers Communications (RCI) Misses on Q1 Earnings, Revenues
by Zacks Equity Research
Rogers Communications (RCI) first-quarter 2020 results hurt by weakness in Services revenues and Media segment attributed to coronavirus outbreak.
Gaia (GAIA) to Report Q1 Earnings: What's in the Cards?
by Zacks Equity Research
Gaia's (GAIA) first-quarter earnings are expected to have gained from strengthened subscriber base.
5 Top Small-Cap Stocks Braving Coronavirus Bloodbath
by Nalak Das
A handful of small-cap stocks have skyrocketed defying the coronavirus-induced market mayhem and extreme volatility.
Netflix's (NFLX) Q1 Earnings Miss, Coronavirus Aids User Growth
by Zacks Equity Research
Netflix (NFLX) adds 15.77 million subscribers in the first quarter of 2020, better than management's expectation of 7 million, driven by coronavirus-induced stay-at-home routine.